Intocell Plunges on Patent Issue…Bridge Biotherapeutics, FutureChem gains[K-Bio Pulse]

• 임정요
• 2025.07.10
• 오전 08:09

• BioPlus
• HUGRO
• PharmEdaily

BioPlus Showcases HUGRO at TAS 2025, Eyes U.S. Market

• 김새미
• 2025.07.09
• 오전 08:59

PharmaResearch Rallies Upon Scrapping Spin-off; Orum and Y-Biologics gains[K-Bio Pulse]

• 임정요
• 2025.07.09
• 오전 07:51

• BioPlus
• PharmEdaily

BioPlus, Generation Co. Sign MOU for Korean Launch of DVS-HA Filler

• 김새미
• 2025.07.08
• 오전 08:59

Ildong Joins Obesity Drug Race; Alteogen Floats KOSPI Relisting[K-Bio Pulse]

• 임정요
• 2025.07.08
• 오전 07:59

• PharmEdaily
• Syntekabio
• Interbiz

Syntekabio Showcases AI Drug Platform at Interbiz 2025

• 송영두
• 2025.07.07
• 오후 02:53

• PharmEdaily
• Celltrion

Celltrion Gains on Earnings Outlook; Organoids Back in Spotlight [K-bio pulse]

• 김진수
• 2025.07.07
• 오전 07:10

• BioPlus
• HUGRO
• PharmEdaily

“BioPlus Expands HUGRO Global Strategy with New Pangyo HQ”

• 김새미
• 2025.07.04
• 오후 01:06

• Pharmedaily

Rokit Healthcare Surges on AI Skin Cancer Regeneration Breakthrough[K-bio Pulse]

• 신민준
• 2025.07.04
• 오전 07:00

• 팜이데일리

Medipost Drops, Corestem Soars as FDA Paths Diverge[K-Bio Pulse]

• 나은경
• 2025.07.03
• 오전 09:00